Intellipharmaceutics International Inc. (Nasdaq: IPCI) provided an update on its RexistaTM, henceforth referred to as Oxycodone Hydrochloride Extended-Release Tablets (“Oxycodone ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE